Literature DB >> 1621505

The changing pattern of human immunodeficiency virus-associated cerebral toxoplasmosis: a study of 46 postmortem cases.

C Strittmatter1, W Lang, O D Wiestler, P Kleihues.   

Abstract

Frequency, pathogenesis and morphological features of toxoplasmosis were assessed in a consecutive autopsy study. Among 204 patients who died from AIDS in Zurich during 1981-1990, 46 (23%) showed morphological evidence of cerebral toxoplasmosis. In 38 out of 46 cases (83%), toxoplasmosis was restricted to the central nervous system (CNS) and, therefore, pathogenetically classified as reactivation of a latent infection. Acute, systemic toxoplasmosis most frequently involved heart and lungs in addition to the CNS and was observed in 7 cases (15%). These patients probably acquired the infection during HIV-induced immunosuppression. Latent infection with intracerebral tissue cysts but no inflammatory response was present in only one case. Diffuse, necrotizing toxoplasma encephalitis with widespread, confluent areas of necrosis was mainly observed during the early period of the AIDS epidemic and restricted to 6 patients (13%) who did not receive chemotherapy. The majority of patients (83%) had multiple, macroscopically well-circumscribed abscesses with preferential location in the cerebral hemispheres. Of all CNS regions, the rostral basal ganglia were most frequently affected (78% of cases). Since 1989, chronic, burnt-out lesions were observed. These were mainly composed of lipid-laden macrophages and immunocytochemistry for Toxoplasma gondii usually failed to detect the parasite. This changing pattern of CNS lesions probably reflects improved clinical management of patients with AIDS.

Entities:  

Mesh:

Year:  1992        PMID: 1621505     DOI: 10.1007/bf00310023

Source DB:  PubMed          Journal:  Acta Neuropathol        ISSN: 0001-6322            Impact factor:   17.088


  32 in total

1.  [TOXOPLASMOSIS IN SWITZERLAND)].

Authors:  E HURWITZ
Journal:  Schweiz Med Wochenschr       Date:  1965-01-16

2.  Neuropathology of the acquired immune deficiency syndrome (AIDS): a report of 135 consecutive autopsy cases from Switzerland.

Authors:  W Lang; J Miklossy; J P Deruaz; G P Pizzolato; A Probst; T Schaffner; E Gessaga; P Kleihues
Journal:  Acta Neuropathol       Date:  1989       Impact factor: 17.088

3.  Immunosuppression and toxoplasmic encephalitis: clinical and experimental aspects.

Authors:  J K Frenkel; B M Nelson; J Arias-Stella
Journal:  Hum Pathol       Date:  1975-01       Impact factor: 3.466

4.  Neuropathology of acquired immune deficiency syndrome (AIDS) in 53 autopsy cases with particular emphasis on microglial nodules and multinucleated giant cells.

Authors:  T Kato; A Hirano; J F Llena; H M Dembitzer
Journal:  Acta Neuropathol       Date:  1987       Impact factor: 17.088

5.  Central-nervous-system toxoplasmosis in homosexual men and parenteral drug abusers.

Authors:  B Wong; J W Gold; A E Brown; M Lange; R Fried; M Grieco; D Mildvan; J Giron; M L Tapper; C W Lerner
Journal:  Ann Intern Med       Date:  1984-01       Impact factor: 25.391

6.  Toxoplasmic encephalitis in patients with acquired immune deficiency syndrome.

Authors:  B J Luft; R G Brooks; F K Conley; R E McCabe; J S Remington
Journal:  JAMA       Date:  1984-08-17       Impact factor: 56.272

7.  Progressive diffuse leukoencephalopathy in patients with acquired immune deficiency syndrome (AIDS).

Authors:  P Kleihues; W Lang; P C Burger; H Budka; M Vogt; R Maurer; R Lüthy; W Siegenthaler
Journal:  Acta Neuropathol       Date:  1985       Impact factor: 17.088

8.  Pathology of the central nervous system in 40 cases of acquired immune deficiency syndrome (AIDS).

Authors:  F Gray; R Gherardi; C Keohane; M Favolini; A Sobel; J Poirier
Journal:  Neuropathol Appl Neurobiol       Date:  1988 Sep-Oct       Impact factor: 8.090

9.  Toxoplasma gondii infection of the central nervous system. Use of the peroxidase-antiperoxidase method to demonstrate toxoplasma in formalin fixed, paraffin embedded tissue sections.

Authors:  F K Conley; K A Jenkins; J S Remington
Journal:  Hum Pathol       Date:  1981-08       Impact factor: 3.466

10.  Cerebral toxoplasmosis complicating the acquired immune deficiency syndrome: clinical and neuropathological findings in 27 patients.

Authors:  B A Navia; C K Petito; J W Gold; E S Cho; B D Jordan; R W Price
Journal:  Ann Neurol       Date:  1986-03       Impact factor: 10.422

View more
  13 in total

1.  Levels of nitric oxide, gamma interferon and interleukin-12 in AIDS patients with toxoplasmic encephalitis.

Authors:  D Torre; C Zeroli; G Ferrario; A Pugliese; F Speranza; A Orani; S Casari; P Bassi; A Poggio; G P Carosi; G P Fiori
Journal:  Infection       Date:  1999 May-Jun       Impact factor: 3.553

2.  Toxoplasma encephalitis in congenic B10 and BALB mice: impact of genetic factors on the immune response.

Authors:  M Deckert-Schlüter; D Schlüter; D Schmidt; G Schwendemann; O D Wiestler; H Hof
Journal:  Infect Immun       Date:  1994-01       Impact factor: 3.441

3.  Limited value of cerebrospinal fluid for direct detection of Toxoplasma gondii in toxoplasmic encephalitis associated with AIDS.

Authors:  C Eggers; U Gross; H Klinker; B Schalke; H J Stellbrink; K Kunze
Journal:  J Neurol       Date:  1995-10       Impact factor: 4.849

4.  Evaluation of risk and diagnostic value of quantitative assays for anti-Toxoplasma gondii immunoglobulin A (IgA), IgE, and IgM and analytical study of specific IgG in immunodeficient patients.

Authors:  J M Pinon; F Foudrinier; G Mougeot; C Marx; D Aubert; O Toupance; G Niel; M Danis; P Camerlynck; G Remy
Journal:  J Clin Microbiol       Date:  1995-04       Impact factor: 5.948

Review 5.  Impact of Plant-Based Foods and Nutraceuticals on Toxoplasma gondii Cysts: Nutritional Therapy as a Viable Approach for Managing Chronic Brain Toxoplasmosis.

Authors:  Sijie Tan; Wen Han Tong; Ajai Vyas
Journal:  Front Nutr       Date:  2022-02-25

6.  Development of Neurological Mouse Model for Toxoplasmosis Using Toxoplasma gondii Isolated from Chicken in Kenya.

Authors:  John Mokua Mose; David Muchina Kamau; John Maina Kagira; Naomi Maina; Maina Ngotho; Adele Njuguna; Simon Muturi Karanja
Journal:  Patholog Res Int       Date:  2017-05-24

7.  Toxoplasma gondii LCAT Primarily Contributes to Tachyzoite Egress.

Authors:  Aric J Schultz; Vern B Carruthers
Journal:  mSphere       Date:  2018-02-28       Impact factor: 4.389

Review 8.  Chronic sequelae of foodborne disease.

Authors:  J A Lindsay
Journal:  Emerg Infect Dis       Date:  1997 Oct-Dec       Impact factor: 6.883

9.  Differential innate immune response programs in neuronal subtypes determine susceptibility to infection in the brain by positive-stranded RNA viruses.

Authors:  Hyelim Cho; Sean C Proll; Kristy J Szretter; Michael G Katze; Michael Gale; Michael S Diamond
Journal:  Nat Med       Date:  2013-03-03       Impact factor: 53.440

Review 10.  Toxoplasma gondii: Entry, association, and physiological influence on the central nervous system.

Authors:  Oscar A Mendez; Anita A Koshy
Journal:  PLoS Pathog       Date:  2017-07-20       Impact factor: 6.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.